Background Medicinal cannabinoids, including medicinal cannabis and pharmaceutical
cannabinoids and their synthetic derivatives, such as tetrahydrocannabinol (THC) and …

In the past two decades, there has been an increasing interest in the therapeutic potential of
cannabinoids for neurological disorders such as epilepsy, multiple sclerosis, pain, and …

Abstract Autism Spectrum Disorder (ASD) is characterized by persistent deficits in social
communication, restricted and repetitive patterns of behavior, interests, or activities and often …

We conducted a review of systematic reviews (SRs) and randomized-controlled trials (RCTs)
to analyze efficacy and safety of cannabis-based medication in patients with mental …

The core symptoms and co-morbidities associated with autism spectrum disorders (ASD)
affect daily living and quality of life. Existing pharmacological interventions are only able to …

Recent studies highlight the role of excessive mind wandering in attention-
deficit/hyperactivity disorder (ADHD) and its association with impairment. We believe …

Introduction: Substance use disorder (SUD) is very common amongst patients with attention
deficit hyperactivity disorder (ADHD). The two disorders share partially overlapping features …

This paper presents a detailed patient case report of a male patient who was diagnosed in
adulthood (aged 33) with attention deficit hyperactivity disorder (ADHD) and treated initially …

Childhood attention-deficit/hyperactivity disorder (ADHD) is prospectively linked to
substance use and disorder. Depression emerging in adolescence is an understudied risk …

Endocannabinoid system involvement in autism spectrum disorder: An overview with
potential therapeutic applications Page 1 AIMS Molecular Science, 6(1): 27–37. DOI:10.3934/molsci.2019.1.27 …